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Abstract: Ocular motor disorders are a well recognized feature of multiple sclerosis (MS). 
Clinical abnormalities of eye movements, early in the disease course, are associated with 
generalized disability, probably because the burden of disease in affected patients falls on the 
brainstem and cerebellar pathways, which are important for gait and balance. Measurement of 
eye movements, especially when used to detect internuclear ophthalmoplegia (INO), may aid 
diagnosis of MS. Measurement of the ocular following response to moving sinusoidal gratings 
of speciﬁ  ed spatial frequency and contrast can be used as an experimental tool to better under-
stand persistent visual complaints in patients who have suffered optic neuritis. Patients with 
MS who develop acquired pendular nystagmus often beneﬁ  t from treatment with gabapentin 
or memantine.
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Introduction
No evaluation of a patient either suspected or diagnosed with MS is complete without 
a systematic examination of their vision and eye movements (Leigh and Zee 2006). 
Although disturbances of vision and eye movements are recognized as important for 
making the diagnosis of MS, the neuro-ophthalmologic examination also provides 
insights into the nature of the disorder in any patient and even in estimating prognosis 
(Frohman et al 2005). Here we review four aspects of the role of eye movements in 
MS: (1) the value of clinical examination of eye movements in making the diagnosis 
and estimating the prognosis in MS; (2) how measurement of eye movements 
may contribute to the diagnosis of MS; (3) how eye movements can be used as an 
experimental tool to investigate the visual disturbance due to optic neuritis; and (4) 
current concepts of treatment of acquired forms of nystagmus due to MS and their 
visual consequences.
Clinical examination of eye movements
A systematic examination of eye movements in patients with MS shows a range of 
disorders (Table 1). The most common eye movement abnormalities are saccadic 
dysmetria, internuclear ophthalmoplegia (INO), disorders of the vestibulo-ocular 
reﬂ  ex (VOR), and gaze-evoked nystagmus (Downey et al 2002; Serra et al 2003; 
Derwenskus et al 2005). Saccades are the rapid, brief eye movements by which we 
shift the point of ﬁ  xation from one feature of interest to the next. Normal subjects 
show mild undershoots (hypometria), especially for larger saccades; however, with 
repetitive saccades, the eye lands on the visual target. Patients with MS may show 
persistent dysmetria, including overshoots (hypermetria) and directional dysmetria 
(eg, an inappropriate vertical component during a horizontal saccade, requiring Clinical Ophthalmology 2007:1(3) 268
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a vertical corrective movement). In normal subjects, 
saccades of each eye are conjugate vertically, but are mildly 
disjunctive horizontally, with the abducting eye initially 
leading (producing transient divergence) and the adducting 
eye eventually catching up (causing transient convergence) 
(Collewijn et al 1988). This minor, transient disconjugacy of 
horizontal saccades in normal subjects cannot be discerned 
at the bedside. However, in INO, the adducting movement is 
visibly slowed (adduction lag) compared with the abducting 
movement. Slowing of adduction occurs because the pulse 
of innervation that causes rapid contraction of the medial 
rectus muscle is deﬁ  cient, since the demyelinated axons of 
the medial longitudinal fasciculus (MLF) cannot conduct the 
high-frequency discharge (Leigh and Zee 2006). In classic 
INO, the ﬁ  ndings include restricted adduction and adduction 
lag in the eye ipsilateral to the MLF lesion and dissociated 
abducting “nystagmus” of the contralateral eye (which is 
discussed in the last section). Milder forms of INO cause 
adduction lag but no restriction of adduction or abducting 
“nystagmus” (Crane et al 1983; Müri and Meienberg 1985). 
This adduction lag is most easily visualized with rapid eye 
movements; thus, INO is best detected by testing saccades, 
and may be missed if only pursuit movements are examined 
(“follow my ﬁ  nger”).
The VOR is most conveniently tested at the bedside 
using the head impulse test: a small but rapid head turn is 
evoked by the examiner while the patient views a station-
ary far visual target (Halmagyi and Curthoys 1988). An 
inadequate vestibular response is evidenced by a corrective 
saccade at the end of the head rotation. In patients with 
INO, the horizontal VOR may be impaired in the adducting 
eye. With vertical head rotations, an asymmetry of upward 
versus downward head rotations may be evident since the 
VOR to upward head rotations depends more on the MLF 
than in response to downward head rotations. Patients 
with acute INO may also develop a skew deviation, the 
eye being higher on the side of the lesion. Furthermore, 
some MS patients show deviation of the subjective visual 
vertical, assessed with a simple laser pointer ﬁ  tted with 
inexpensive line-generating optics (Serra et al 2003), or a 
Maddox rod.
Carefully conducted clinical studies have established that 
patients who have abnormal eye movements are more dis-
abled than those with normal motility, and that this difference 
is sustained after two years (Downey et al 2002; Serra et al 
2003; Derwenskus et al 2005). The reason for the increased 
disability in MS patients with abnormal eye movements is 
less due to their impaired vision than to their disturbance of 
gait. In such patients, MRI scans conﬁ  rm that both abnormal 
eye movements and gait disturbance are caused by prominent 
involvement of the brainstem and cerebellar pathways.
Measuring eye movements to aid 
diagnosis of MS
Clinical detection of INO and saccadic abnormalities in MS 
may be challenging (Frohman TC et al 2003), and measure-
ment of eye movements may help conﬁ  rm the diagnosis 
during early stages of the disease. A representative example 
is shown in Figure 1.
Detection of a saccadic abnormality may be better when 
targets are presented randomly, so that neither their time of 
onset nor their location can be predicted. Large saccades 
(20 degrees or greater) are more likely to show changes in 
velocity than are small saccades. In making paired compari-
son of the peak velocity of abducting and adducting saccades, 
it is important to take account of the fact that normal subjects 
show somewhat greater peak velocities in the abducting eye, 
depending on the methodology being used (Collewijn et al 
1988). A more reliable approach is to measure the ratio of 
abducting/adducting movements during horizontal saccades, 
and compare the patient’s value with that of group of normal 
subjects recorded in the same laboratory (Flipse et al 1996; 
Frohman et al 2002; Frohman EM et al 2003). Patients with 
INO have abduction/adduction ratios for peak velocity or 
Table 1 Summary of common disorders of ocular motility in MS (Downey et al 2002)
Abnormal ﬁ  nding  Occurrence in MS patients who show abnormal eye movements
Misalignment of visual axes  32% (usually exotropia)
Gaze-evoked nystagmus  36%
Nystagmus in central position  18% (pendular; downbeat)
Saccadic dysmetria  91% (59% in both planes)
Internuclear ophthalmoplegia  68% (27% bilateral)
Smooth pursuit impaired  32%
Vestibulo-ocular reﬂ  ex impaired  36%
Vergence impaired  23%
Abbreviation:   VOR, vestibulo-ocular reﬂ  ex.Clinical Ophthalmology 2007:1(3) 269
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peak acceleration that lie outside the 95% prediction intervals 
for normal subjects. Another approach is to plot eye velocity 
versus eye displacement (position) for each eye – phase plane 
plots. Normal subjects show very similar initial phase-plane 
plots for each eye whereas in INO, the plots of each eye 
deviate at the start of the movement.
Other saccadic abnormalities in multiple sclerosis include 
increased reaction time (latency), inaccuracy (dysmetria), 
and decreased velocity (Reulen et al 1983; Brigell et al 
1988; Meienberg et al 1986). Some patients with MS show 
saccadic oscillations or unwanted saccades that intrude on 
steady ﬁ  xation or smooth pursuit (Herishanu and Sharpe 
1983; Ashe et al 1991; Schon et al 2001).
Smooth-pursuit tracking may be impaired (reduced 
gain) (Sharpe et al 1981; Reulen et al 1983), and there may 
be impaired cancellation of the horizontal vestibulo-ocular 
reﬂ  ex (VOR) when patients attend to a head-ﬁ  xed target 
during rotation in a chair (Sharpe et al 1981). Unilateral 
internuclear ophthalmoplegia may impair asymmetrically 
the vertical vestibulo-ocular reﬂ  ex during stimulation of the 
contralateral posterior semicircular canal, which depends 
on the medial longitudinal fasciculus for normal responses 
(Cremer et al 1999). Bilateral internuclear ophthalmoplegia 
impairs the vertical vestibulo-ocular reﬂ  ex, gaze holding, 
smooth pursuit, and eye-head tracking – all functions that 
also depend on the medial longitudinal fasciculus (Ranalli 
and Sharpe 1988). Patients with head tremor and an impaired 
vestibulo-ocular reﬂ  ex may report oscillopsia – illusory 
motion of the visual world (Proudlock et al 2002).
Less commonly, MS may cause horizontal and verti-
cal gaze palsies (Wall and Wray 1983; Martyn and Kean 
1988; Tan and Kansu 1990; Milea et al 2001), or individual 
oculomotor, trochlear or abducens palsies due to brainstem 
plaques (Leigh and Zee 2006), upbeat and downbeat nystag-
mus (Fisher et al 1983; Masucci and Kurtzke 1988; Baloh 
and Yee 1989), and a range of vestibular and optokinetic 
abnormalities (Katsarkas 1982; Huygen et al 1990; Todd 
et al 2001). MRI often aids identiﬁ  cation of brainstem or 
cerebellar lesions responsible for such abnormalities; thin 
cuts and proton density images may be required.
Diagnosis of multiple sclerosis depends on demonstra-
tion of lesions disseminated throughout the nervous system 
(Frohman et al 2005). Early diagnosis has become more 
important because prompt initiation of immunotherapy has 
the best chance of arresting the disease. Although detection of 
subtle deﬁ  cits of ocular motility, such as INO, may be useful 
in making a diagnosis, some caution is required since these 
tests are not speciﬁ  c for multiple sclerosis. Thus, the clinician 
must weigh the results of ocular motor studies with other 
clinical or laboratory ﬁ  ndings before making a diagnosis in 
the context of current criteria (Dalton et al 2002). Routine 
examination of eye movements during follow-up visits to the 
MS clinic (along with careful evaluation of vision) may pro-
vide a useful method of evaluating progress and prognosis. 
As noted above, patients who are more generally disabled 
are more likely to develop abnormalities of eye movements, 
probably because the brunt of the disease is affecting brain-
stem and cerebellar connections (Downey et al 2002; Serra 
et al 2003; Derwenskus et al 2005).
Application of eye movements to 
investigate visual disorders in MS
The signature disturbance of vision in MS is optic neuritis, 
which typically presents as monocular loss of central vision, 
accompanied by discomfort with eye movements (Frohman 
et al 2005). Thanks to the longitudinal Optic Neuritis Treat-
ment study, we now have a more detailed knowledge of 
the clinical characteristics and course of the syndrome, in 
which over 95% of patients recover 20/40 or better vision 
Figure 1 Comparison of a rightward saccade made to a 22 degree target jump 
by a normal subject (A) and a patient with MS who has INO (B). Note how the 
normal subject’s eyes move together, with right eye (abduction) velocity being 
slightly bigger than that of the left eye. In contrast, the MS patient’s adducting left 
eye lags behind the abducting right, and right eye velocity greatly exceeds that of 
the left. Positive values indicate rightward movements. Note the different axes for 
position and velocity.
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by 12 months after the onset of symptoms (Beck and Cleary 
1993; Atkins et al 2006).
Some patients who suffer optic neuritis make a good 
recovery of vision as tested by high-contrast Snellen opto-
types but show residual visual impairment, particularly with 
contrast sensitivity and with low-contrast optotypes such as 
Sloan letters (Balcer et al 2003). Color vision may also be 
asymmetrically impaired in such patients.
We recently investigated whether motion vision could 
remain compromised after recovery from optic neuritis 
in a 42-year-old man with MS (Rucker et al 2006). Three 
years after left optic neuritis had reduced his vision to 
counting ﬁ  ngers, his visual acuity had improved to 20/40 
OS (20/20 OD) with Snellen letters but remained at 20/200 
OS (20/32 OD) with Sloan letters at 10% contrast. Color 
vision was normal OD but essentially absent OS. Despite 
this improvement, he reported subjective visual difﬁ  culties 
OS, which he noted while he was in motion. Rather than 
perform a subjective test of motion vision, we measured his 
ocular following response (OFR). The OFR is a measure of 
ﬁ  rst-order, luminance driven motion vision which consists 
of a sudden conjugate eye movement elicited at ultra-short 
latencies by rapid shift of a large visual stimulus (Sheliga 
et al 2005). One advantage of studying motion vision by 
measuring the short-latency OFR is that this eye-tracking 
response is rather automatic and not substantially inﬂ  uenced 
by the level of attentiveness of the subject. The stimuli we 
applied consisted of ¼-cycle shifts of a sine-wave grating 
with a spatial frequency of either 0.153 or 0.458 cycles/
degree. We found that his responses to the higher spatial 
frequency stimulus were impaired in the affected left eye, 
suggesting predominant post-optic neuritis involvement of 
parvocellular visual function (Figure 2). Responses to the 
low spatial frequency stimulus were similar between the two 
eyes and to controls, suggesting preservation of the mag-
nocellular visual function, which may function as a visual 
ﬁ  eld-holding reﬂ  ex (Miles 1998). Although OFR has been 
applied to patients with cortical disturbances of vision, this 
preliminary study suggests that OFR may be a valuable, 
objective means of further study of visual dysfunction fol-
lowing optic neuritis.
Acquired nystagmus in MS 
and treatment of its visual 
consequences
Several forms of nystagmus occur in MS. So-called dissoci-
ated nystagmus with INO is more correctly classiﬁ  ed as a 
disorder of saccadic metrics: the adducting eye fails to get 
on target, and the brain then programs a series of corrective 
saccades that are not evident in the paretic, adducting eye, 
but are observed in the abducting eye (Leigh and Zee 2006). 
Patching the affected eye in unilateral INO for several days 
reduces “dissociated nystagmus” while patching the normal 
eye increases it, indicating that plastic-adaptive mechanisms 
contribute to the nystagmus (Zee et al 1987).
Although upbeat, downbeat, and seesaw nystagmus all 
may occur in MS, it is acquired pendular nystagmus (APN) 
that is most visually disabling. APN is also a feature of other 
disorders of central myelin, including Pelizaeus-Merzbacher 
disease (Trobe et al 1991), peroxisomal assembly disorders 
(Kori et al 1998), and in toluene abuse (Maas et al 1991). 
Since patients with MS who have pendular nystagmus often 
also have evidence of optic nerve demyelination, it follows 
that prolonged response time of the visual processing might 
be responsible for the ocular oscillations. Support for this 
hypothesis comes from the observation that oscillations are 
usually larger in the eye with evidence of more severe optic 
nerve demyelination (Barton and Cox 1993). However, the 
nystagmus often remains unchanged in darkness (when visual 
inputs have no inﬂ  uence on eye movements). Furthermore, 
spontaneous ocular oscillations can be induced in normal 
subjects by experimentally delaying the latency of visual 
feedback during ﬁ  xation; however, the frequency of these 
induced oscillations is less than 2 Hz, which is lower than in 
Figure 2 Representative mean right-left velocity proﬁ  les of the ocular following 
responses (OFR) versus time elicited in a patient with MS who had partially recov-
ered from a left optic neuritis. The patient responded to successive ¼-wavelength 
shifts applied to 1f stimuli (left column) and 3f stimuli (right column) of different 
contrast (contrast of the pattern is shown by encircled numbers superimposed 
on traces). A and B: right-eye-viewing sessions (REV). C and D: left-eye-viewing 
sessions (LEV). Note the smaller LEV responses to the 3f stimuli versus 1f stimuli. 
Adapted from (Rucker et al 2006).
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most patients with pendular nystagmus due to multiple scle-
rosis (Averbuch-Heller et al 1995). Furthermore, when this 
experimental technique was applied to patients with acquired 
pendular nystagmus, it did not change the characteristics of 
the nystagmus, but instead superimposed lower-frequency 
oscillations similar to those induced in normal subjects 
(Averbuch-Heller et al 1995). Thus, disturbance of visual 
ﬁ  xation due to visual delays cannot wholly account for the 
high-frequency oscillations that often characterize acquired 
pendular nystagmus.
An important observation concerning acquired pendular 
nystagmus in multiple sclerosis is that some patients show 
transient suppression of their oscillations following a sac-
cade (Figure 3). Systematic comparison of the oscillations 
prior to, and following, a saccade has demonstrated that the 
oscillations are phase-shifted (reset) leading to the hypoth-
esis that the oscillations of APN in patients with multiple 
sclerosis arise in the neural integrator for eye movements, 
and that large saccades affect the timing of the oscillations 
by “resetting” the integrator with the large pulse of neural 
activity (Das et al 2000). The nucleus prepositus hypoglossi 
and medial vestibular nucleus are important components 
of the neural integrator, which is probably affected by 
feedback of signals via cell groups of the paramedian tracts 
(PMT) to the cerebellar ﬂ  occulus (Leigh and Zee 2006). 
Patients with APN show a preponderance of multiple scle-
rosis plaques in their paramedian pons in the region of the 
PMT cell groups (Lopez et al 1995). Thus, it is postulated 
that the neural integrator loses normal feedback, becomes 
unstable, and begins to oscillate, causing acquired pendular 
nystagmus. The neurotransmitters used by neurons that con-
tribute to normal neural integration of ocular motor signals 
are know to include glutamate and gabapentin (Straube 
et al 1991; Arnold et al 1999). This has led to clinical tri-
als that have demonstrated gabapentin (Averbuch-Heller 
et al 1997; Bandini et al 2001), and memantine (Starck 
et al 1997) may ameliorate the visually disabling acquired 
pendular nystagmus that occurs in multiple sclerosis. Our 
personal experience is that most patients with APN due to 
MS visually beneﬁ  t from either gabapentin or memantine. 
Both drugs are usually well tolerated, although gabapentin 
sometimes increases ataxia.
Summary
In the past twenty years, eye movements have moved beyond 
the bounds of neuro-ophthalmology and are now widely used 
by neuroscientists, visual scientists, and psychologists, as 
well as clinicians in several specialties. The popularity of eye 
movements as an experimental tool arises, in part, because 
they can be conveniently and accurately measured and 
analyzed, but also because much is known concerning their 
neural substrate. It is therefore, no surprise, that eye move-
ments have been commonly applied to better understand the 
visual and motor disorders in patients with MS. In this review 
we draw attention to how eye movements can aid diagnosis 
of MS at the bedside and in the laboratory. In addition, eye 
movements can be used as an experimental took to better 
understand the disorders of vision that occur in MS. Finally, 
better knowledge concerning neuropharmacology has led to 
effective drug treatments for abnormal eye movements that 
degrade vision in patients with demyelinating disease.
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